Global Amyotrophic Lateral Sclerosis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 150346
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 116
  • list Pharmaceuticals and Healthcare

Amyotrophic lateral sclerosis (ALS) is a group of rare neurological diseases that mainly involve the nerve cells (neurons) responsible for controlling voluntary muscle movement.

Scope of the Report:

Developing medical infrastructure in the emerging economies is expected to drive the growth of Amyotrophic lateral sclerosis market in these economies in the near future.

The global Amyotrophic Lateral Sclerosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Amyotrophic Lateral Sclerosis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Amyotrophic Lateral Sclerosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Amyotrophic Lateral Sclerosis market by product type and applications/end industries.

Market Segment by Companies, this report covers

GNT Pharma

Synthetic Biologics

Avicena

Amkor Pharma

Mitsubishi Tanabe Pharma

Sanofi

Biogen

Apotex

Mylan Pharmaceuticals

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Stem Cell Therapy

Chemotherapy

Market Segment by Applications, can be divided into

Hospitals

Diagnostic Centres

Clinics

Retail Pharmacies

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Amyotrophic Lateral Sclerosis Market Overview

1.1 Product Overview and Scope of Amyotrophic Lateral Sclerosis

1.2 Classification of Amyotrophic Lateral Sclerosis by Types

1.2.1 Global Amyotrophic Lateral Sclerosis Revenue Comparison by Types (2017-2023)

1.2.2 Global Amyotrophic Lateral Sclerosis Revenue Market Share by Types in 2017

1.2.3 Stem Cell Therapy

1.2.4 Chemotherapy

1.3 Global Amyotrophic Lateral Sclerosis Market by Application

1.3.1 Global Amyotrophic Lateral Sclerosis Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Diagnostic Centres

1.3.4 Clinics

1.3.5 Retail Pharmacies

1.4 Global Amyotrophic Lateral Sclerosis Market by Regions

1.4.1 Global Amyotrophic Lateral Sclerosis Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Amyotrophic Lateral Sclerosis Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Amyotrophic Lateral Sclerosis Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Amyotrophic Lateral Sclerosis Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Amyotrophic Lateral Sclerosis Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Amyotrophic Lateral Sclerosis Status and Prospect (2013-2023)

1.5 Global Market Size of Amyotrophic Lateral Sclerosis (2013-2023)

2 Manufacturers Profiles

2.1 GNT Pharma

2.1.1 Business Overview

2.1.2 Amyotrophic Lateral Sclerosis Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GNT Pharma Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.2 Synthetic Biologics

2.2.1 Business Overview

2.2.2 Amyotrophic Lateral Sclerosis Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.3 Avicena

2.3.1 Business Overview

2.3.2 Amyotrophic Lateral Sclerosis Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Avicena Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.4 Amkor Pharma

2.4.1 Business Overview

2.4.2 Amyotrophic Lateral Sclerosis Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Amkor Pharma Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.5 Mitsubishi Tanabe Pharma

2.5.1 Business Overview

2.5.2 Amyotrophic Lateral Sclerosis Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.6 Sanofi

2.6.1 Business Overview

2.6.2 Amyotrophic Lateral Sclerosis Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sanofi Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.7 Biogen

2.7.1 Business Overview

2.7.2 Amyotrophic Lateral Sclerosis Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Biogen Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.8 Apotex

2.8.1 Business Overview

2.8.2 Amyotrophic Lateral Sclerosis Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Apotex Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

2.9 Mylan Pharmaceuticals

2.9.1 Business Overview

2.9.2 Amyotrophic Lateral Sclerosis Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Mylan Pharmaceuticals Amyotrophic Lateral Sclerosis Revenue, Gross Margin and Market Share (2016-2017)

3 Global Amyotrophic Lateral Sclerosis Market Competition, by Players

3.1 Global Amyotrophic Lateral Sclerosis Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Amyotrophic Lateral Sclerosis Players Market Share

3.2.2 Top 10 Amyotrophic Lateral Sclerosis Players Market Share

3.3 Market Competition Trend

4 Global Amyotrophic Lateral Sclerosis Market Size by Regions

4.1 Global Amyotrophic Lateral Sclerosis Revenue and Market Share by Regions

4.2 North America Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

4.3 Europe Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

4.5 South America Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

5 North America Amyotrophic Lateral Sclerosis Revenue by Countries

5.1 North America Amyotrophic Lateral Sclerosis Revenue by Countries (2013-2018)

5.2 USA Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

5.3 Canada Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

5.4 Mexico Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

6 Europe Amyotrophic Lateral Sclerosis Revenue by Countries

6.1 Europe Amyotrophic Lateral Sclerosis Revenue by Countries (2013-2018)

6.2 Germany Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

6.3 UK Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

6.4 France Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

6.5 Russia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

6.6 Italy Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue by Countries

7.1 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue by Countries (2013-2018)

7.2 China Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

7.3 Japan Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

7.4 Korea Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

7.5 India Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

8 South America Amyotrophic Lateral Sclerosis Revenue by Countries

8.1 South America Amyotrophic Lateral Sclerosis Revenue by Countries (2013-2018)

8.2 Brazil Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

8.3 Argentina Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

8.4 Colombia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Amyotrophic Lateral Sclerosis by Countries

9.1 Middle East and Africa Amyotrophic Lateral Sclerosis Revenue by Countries (2013-2018)

9.2 Saudi Arabia Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

9.3 UAE Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

9.4 Egypt Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

9.5 Nigeria Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

9.6 South Africa Amyotrophic Lateral Sclerosis Revenue and Growth Rate (2013-2018)

10 Global Amyotrophic Lateral Sclerosis Market Segment by Type

10.1 Global Amyotrophic Lateral Sclerosis Revenue and Market Share by Type (2013-2018)

10.2 Global Amyotrophic Lateral Sclerosis Market Forecast by Type (2018-2023)

10.3 Stem Cell Therapy Revenue Growth Rate (2013-2023)

10.4 Chemotherapy Revenue Growth Rate (2013-2023)

11 Global Amyotrophic Lateral Sclerosis Market Segment by Application

11.1 Global Amyotrophic Lateral Sclerosis Revenue Market Share by Application (2013-2018)

11.2 Amyotrophic Lateral Sclerosis Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Diagnostic Centres Revenue Growth (2013-2018)

11.5 Clinics Revenue Growth (2013-2018)

11.6 Retail Pharmacies Revenue Growth (2013-2018)

12 Global Amyotrophic Lateral Sclerosis Market Size Forecast (2018-2023)

12.1 Global Amyotrophic Lateral Sclerosis Market Size Forecast (2018-2023)

12.2 Global Amyotrophic Lateral Sclerosis Market Forecast by Regions (2018-2023)

12.3 North America Amyotrophic Lateral Sclerosis Revenue Market Forecast (2018-2023)

12.4 Europe Amyotrophic Lateral Sclerosis Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Amyotrophic Lateral Sclerosis Revenue Market Forecast (2018-2023)

12.6 South America Amyotrophic Lateral Sclerosis Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Amyotrophic Lateral Sclerosis Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Amyotrophic Lateral Sclerosis Picture

Table Product Specifications of Amyotrophic Lateral Sclerosis

Table Global Amyotrophic Lateral Sclerosis and Revenue (Million U

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery